Ro-25-2636

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameRo-25-2636

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLeukotriene B4 receptor antagonists

TargetsLeukotriene B4 receptor

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoche Holding Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesRoche Holding Ag

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A